Conduit Pharmaceuticals Inc. (NASDAQ:CDT), a Delaware-based pharmaceutical company ... In an attempt to address the issue, stockholders at the company's annual meeting held on Wednesday approved an ...

Conduit Pharmaceuticals Inc ... meeting held on Wednesday approved an amendment allowing for a reverse stock split at a ratio of not less than 1-for-10 and not more than 1-for-100, at the ...

GoodReturns is your trusted source for the latest financial news, investment insights, and expert guidance. Stay updated and make informed decisions with our comprehensive updates.

The company’s annual meeting resulted in the election of directors, ratification of an accounting firm, and approval of the reverse stock split amendment. More about Conduit Pharmaceuticals YTD ...

The discharge at the axon terminal generates an inhomogeneous electric field that immediately influences target neurons and thus provokes ephaptic coupling. Our measurements are quantitatively ...

In this article, we collected the electroencephalogram (EEG) and electromyogram (EMG) signals synchronously of 21 healthy young adults and explored the enhancement of functional corticomuscular ...